INSULIN Act Gains Momentum with Bipartisan House Introduction
Diabetes Leadership Council and Diabetes Patient Advocacy Coalition support bipartisan effort to expand access to affordable insulin; encourage swift bill passage.
WASHINGTON, D.C., September 3, 2026
Today, U.S. Representatives Diana DeGette, Mariannette Miller-Meeks, Kim Schrier, Rob Bresnahan, and Angie Craig introduced the bipartisan Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act in the U.S. House of Representatives, building momentum for legislation that would make insulin more affordable and accessible for millions of Americans living with diabetes.
The Diabetes Leadership Council (DLC) and Diabetes Patient Advocacy Coalition (DPAC) support the INSULIN Act and appreciate the Representatives’ bipartisan efforts to expand access to affordable insulin.
More than 40 million people in the United States have diabetes. People with Type 1 diabetes must take insulin for life, and many people with Type 2 diabetes also depend on insulin to manage their blood sugar and prevent serious health complications. While Congress has capped insulin costs at $35 per month for Medicare beneficiaries, millions of Americans with private insurance, as well as those without insurance, still face affordability and access barriers.
“The Diabetes Leadership Council (DLC) and Diabetes Patient Advocacy Coalition (DPAC) applaud and thank Representatives DeGette, Miller-Meeks, Schrier, Bresnahan, and Craig for introducing the INSULIN Act of 2026,” said CEO George Huntley. “This legislation will greatly improve access to affordable insulin for people living with diabetes, and it is time that the $35 monthly insulin copay cap apply to everyone as it does to Medicare beneficiaries today. We look forward to working to get this legislation across the finish line before the end of the 119th Congress.”
The House legislation follows bipartisan progress on the INSULIN Act in the Senate, where the Senate Health, Education, Labor, and Pensions (HELP) Committee advanced the bill in July. The legislation would extend the $35 monthly out-of-pocket insulin cap to people with private and employer-sponsored insurance and would create an insulin resource center and hotline for uninsured individuals. The Senate bill supported by DLC and DPAC also creates a pilot program to help uninsured people access insulin at the same monthly cost.
We urge lawmakers in both chambers to continue working together to pass the INSULIN Act in the 119th Congress and help ensure that people with diabetes can afford the insulin they need.
DLC and DPAC also asks those impacted by diabetes to encourage their Representative to pass the INSULIN Act. Write to Congress directly here.